$430 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 19 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 5.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXK | Buy | ACCELERATE DIAGNOSTICS INC | $73,208,000 | +1.1% | 5,087,456 | +1.0% | 17.04% | -9.5% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $57,897,000 | +43.3% | 2,670,536 | -0.9% | 13.48% | +28.3% |
| TSRO | Buy | TESARO INC | $56,058,000 | +98.6% | 666,956 | +4.1% | 13.05% | +77.8% |
| MZOR | Sell | MAZOR ROBOTICS LTDsponsored ads | $49,742,000 | +37.4% | 2,766,517 | -4.9% | 11.58% | +23.0% |
| QDEL | Sell | QUIDEL CORP | $45,249,000 | +1.9% | 2,533,554 | -1.6% | 10.53% | -8.8% |
| OPK | OPKO HEALTH INC | $36,557,000 | -10.1% | 3,914,000 | 0.0% | 8.51% | -19.5% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $22,387,000 | -15.9% | 3,182,269 | -3.9% | 5.21% | -24.7% |
| ARAY | Sell | ACCURAY INC | $12,885,000 | -12.7% | 2,482,718 | -2.8% | 3.00% | -21.8% |
| BIOL | BIOLASE INC | $12,320,000 | -10.7% | 10,529,525 | 0.0% | 2.87% | -20.0% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $12,294,000 | +38.1% | 5,691,572 | -2.2% | 2.86% | +23.6% |
| HNSN | HANSEN MEDICAL | $11,702,000 | 0.0% | 4,491,820 | 0.0% | 2.72% | -10.5% | |
| XON | Buy | INTREXON CORP | $11,309,000 | -17.3% | 459,529 | +13.8% | 2.63% | -26.0% |
| VRML | VERMILLION INC | $9,573,000 | -24.5% | 8,624,225 | 0.0% | 2.23% | -32.4% | |
| AGEN | Sell | AGENUS INC | $7,523,000 | -3.9% | 1,857,477 | -1.3% | 1.75% | -14.0% |
| TTHI | TRANSITION THERAPEUTICS INC | $5,612,000 | +14.8% | 3,817,972 | 0.0% | 1.31% | +2.8% | |
| CFRX | CONTRAFECT CORP | $3,416,000 | -15.0% | 1,182,032 | 0.0% | 0.80% | -23.9% | |
| BIIB | BIOGEN INC | $1,625,000 | -7.1% | 6,723 | 0.0% | 0.38% | -16.9% | |
| EYES | SECOND SIGHT MED PRODS INC | $182,000 | -25.7% | 50,804 | 0.0% | 0.04% | -34.4% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $37,000 | -24.5% | 6,661 | 0.0% | 0.01% | -30.8% | |
| MBLX | Exit | METABOLIX Inc | $0 | – | -726,935 | -100.0% | -0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.